Table 1 The clinicopathological characteristics among BCa patients
Characteristics | Total | Pentafecta attained | Pentafecta not attained | P value |
|---|---|---|---|---|
Patients (n, %) | 340 (100) | 50 (14.7) | 290 (85.4) | |
Mean age, years ± SD | 66.41 ± 11.27 | 62.64 ± 10.36 | 67.07 ± 11.31 | 0.01 |
Gender (n, %) | 0.317 | |||
Male | 288 (84.7) | 40 (80.0) | 248 (85.5) | |
Female | 52 (15.3) | 10 (20.0) | 42 (14.5) | |
Smoking history (yes, %) | 131 (38.5) | 14 (28.0) | 117 (40.3) | 0.136 |
Neoadjuvant chemotherapy (n, %) | 38 (11.2) | 8 (16.0) | 30 (10.3) | 0.241 |
Type of urinary diversion (n, %) | 0.014 | |||
Cutaneous ureterostomy | 173 (50.9) | 16 (32.0) | 157 (54.1) | |
Conduit | 107 (31.5) | 21 (42.0) | 86 (29.7) | |
Orthotopic neobladder | 60 (17.6) | 13 (26.0) | 47 (16.2) | |
Pathological T-stage (%) | 0.488 | |||
pT0 | 29 (8.5) | 1 (2.0) | 28 (9.7) | |
pTa | 25 (7.4) | 3 (6.0) | 22 (7.6) | |
pT1 | 96 (28.2) | 17 (34.0) | 79 (27.2) | |
pT2 | 83 (24.4) | 12 (24.0) | 71 (24.5) | |
pT3 | 65 (19.1) | 9 (18.0) | 56 (19.3) | |
pT4 | 42 (12.4) | 8 (16.0) | 34 (11.7) | |
Pathological N-stage (%) | 0.408 | |||
N0 | 312 (91.8) | 44 (88.0) | 268 (92.4) | |
N1 | 15 (4.4) | 4 (8.0) | 11 (3.8) | |
N2 | 9 (2.6) | 2 (4.0) | 7 (2.4) | |
N3 | 4 (1.2) | 0 (0) | 4 (1.4) | |
No. lymph node removed (mean, ± SD) | 10.46 ± 8.60 | 20.34 ± 4.23 | 8.76 ± 8.0 | < 0.001 |